HC Wainwright Upgrades Caladrius Biosciences To Buy, Sets $1.25 Price Target

By: via Benzinga
Caladrius Biosciences Inc (NASDAQ: CLBS) has recently entered into a global collaboration agreement with Hitachi Chemical ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.